Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal Women
Public ClinicalTrials.gov record NCT00369343. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, 8-week, Double-blind, Placebo-controlled Study Followed by a 6-month Open-label Extension to Evaluate the Efficacy and Safety of DVS SR in Peri- and Postmenopausal Women With Major Depressive Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Desvenlafaxine succinate (DVS) is a potent and selective serotonin and norepinephrine reuptake inhibitor (SNRI). The sustained-release (SR) formulation, DVS SR, is being studied in the development program for the treatment of major depressive disorder (MDD), for vasomotor symptoms (VMS) associated with menopause, and for pain associated with peripheral diabetic neuropathy, as well as for the treatment of fibromyalgia syndrome. This study will investigate the safety, efficacy, and tolerability of DVS SR in women with MDD who are peri- and postmenopausal.
Study identification
- NCT ID
- NCT00369343
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 381 participants
Conditions and interventions
Interventions
- Desvenlafaxine administered as a succinate salt in a sustained-release form (DVS SR) Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years to 70 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2006
- Primary completion
- Oct 31, 2007
- Completion
- Jun 30, 2008
- Last update posted
- May 6, 2012
2006 – 2008
United States locations
- U.S. sites
- 37
- U.S. states
- 23
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35226 | — |
| Not listed | Little Rock | Arkansas | 72223 | — |
| Not listed | Springdale | Arkansas | 72762 | — |
| Not listed | Palo Alto | California | 94305 | — |
| Not listed | San Diego | California | 92103 | — |
| Not listed | New London | Connecticut | 06320 | — |
| Not listed | Bradenton | Florida | 34208 | — |
| Not listed | Miami | Florida | 33133 | — |
| Not listed | Tampa | Florida | 33613 | — |
| Not listed | Winter Park | Florida | 32789 | — |
| Not listed | Atlanta | Georgia | 30308 | — |
| Not listed | Sandy Springs | Georgia | 30328 | — |
| Not listed | Savannah | Georgia | 31406 | — |
| Not listed | Smyrna | Georgia | 30080 | — |
| Not listed | Idaho Falls | Idaho | 83404 | — |
| Not listed | Chicago | Illinois | 60634 | — |
| Not listed | Indianapolis | Indiana | 46202 | — |
| Not listed | Terre Haute | Indiana | 47802 | — |
| Not listed | Shreveport | Louisiana | 71101 | — |
| Not listed | Rockville | Maryland | 20852 | — |
| Not listed | Omaha | Nebraska | 68131 | — |
| Not listed | Cherry Hill | New Jersey | 08002 | — |
| Not listed | Brooklyn | New York | 11235 | — |
| Not listed | Minot | North Dakota | 58701 | — |
| Not listed | Beachwood | Ohio | 44122 | — |
| Not listed | Dayton | Ohio | 45408 | — |
| Not listed | Toledo | Ohio | 43623 | — |
| Not listed | Oklahoma City | Oklahoma | 73118 | — |
| Not listed | Tulsa | Oklahoma | 74135 | — |
| Not listed | Philadelphia | Pennsylvania | 19131 | — |
| Not listed | Hilton Head Island | South Carolina | 29926 | — |
| Not listed | Austin | Texas | 78756 | — |
| Not listed | Houston | Texas | 77007 | — |
| Not listed | Richmond | Virginia | 23229 | — |
| Not listed | Richmond | Virginia | 23230 | — |
| Not listed | Seattle | Washington | 98105 | — |
| Not listed | Brown Deer | Wisconsin | 53223 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00369343, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 6, 2012 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00369343 live on ClinicalTrials.gov.